Literature DB >> 2828771

In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation.

M Luisetti1, M Salmona, E Pozzi, M Genghini, L Spialtini, P Masturzo.   

Abstract

The influence of pharmacological stimulation of pulmonary surfactant synthesis has been studied in rat alveolar spaces. Animals were treated acutely with Ambroxol at a dose of 4 mg/kg b.w./day p.o. and 5 days later the following biochemical and physico-chemical parameters were determined: BAL fluid lecithin content, BAL fluid microviscosity, alveolar macrophage membrane microviscosity, spontaneous generation of superoxide anion by alveolar macrophages, elastase and antielastase activity of BAL fluid. Treatment with Ambroxol significantly increased the lecithin content of BAL fluid and significantly decreased the macrophage plasma membrane microviscosity. A likely consequence of increased lecithin content in alveolar macrophages (an activation of these cells) was suggested by the increase of the spontaneous production of superoxide. Finally, in the BAL fluid of Ambroxol-treated rats the elastase activity was reduced, whereas the elastase inhibitory activity was almost doubled in respect to control rats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828771     DOI: 10.1007/BF02714449

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  31 in total

1.  Activation of alveolar macrophages exposed to lavage-procured immunoglobulin G obtained from normal rabbit lungs.

Authors:  M Ando; M Suga; K Shima; M Sugimoto; H Tokuomi
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

Review 3.  Pathogenic effects of inhaled particles and antigens.

Authors:  A C Allison
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

Review 4.  Pulmonary host defense mechanisms.

Authors:  R N Harada; J E Repine
Journal:  Chest       Date:  1985-02       Impact factor: 9.410

Review 5.  Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis).

Authors:  W D Claypool; R M Rogers; G M Matuschak
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

6.  Morphology and function of alveolar macrophages after long-term nickel exposure.

Authors:  A Johansson; P Camner; C Jarstrand; A Wiernik
Journal:  Environ Res       Date:  1980-10       Impact factor: 6.498

7.  Resolution of plasma membrane lipid fluidity in intact cells labelled with diphenylhexatriene.

Authors:  D Grunberger; R Haimovitz; M Shinitzky
Journal:  Biochim Biophys Acta       Date:  1982-06-28

8.  Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.

Authors:  S O'Neill; E Lesperance; D J Klass
Journal:  Am Rev Respir Dis       Date:  1984-08

9.  Rabbit lungs after long-term exposure to low nickel dust concentration. I. Effects on phospholipid concentration and surfactant activity.

Authors:  T Curstedt; M Hagman; B Robertson; P Camner
Journal:  Environ Res       Date:  1983-02       Impact factor: 6.498

10.  Human methionine sulfoxide-peptide reductase, an enzyme capable of reactivating oxidized alpha-1-proteinase inhibitor in vitro.

Authors:  H Carp; A Janoff; W Abrams; G Weinbaum; R T Drew; H Weissbach; N Brot
Journal:  Am Rev Respir Dis       Date:  1983-03
View more
  2 in total

1.  Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo.

Authors:  G Fegiz
Journal:  Lung       Date:  1991       Impact factor: 2.584

2.  Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report.

Authors:  Nao Oda; Koji Tamai; Yujiro Suzuki; Harukazu Yoshimatsu; Hirofumi Matsuoka; Yusuke Matsumoto; Nobuhiko Okada
Journal:  J Med Case Rep       Date:  2015-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.